Skip to main content
DNA Labs India

GAMT Gene Guanidinoacetate methyltransferase deficiency NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

GAMT Gene Guanidinoacetate methyltransferase deficiency NGS Genetic Test

Short Name: GAMT Gene NGS Genetic Test

Also known as: GAMT Deficiency Test, Creatine Deficiency Syndrome Type 1 Genetic Test, Guanidinoacetate Methyltransferase Gene Sequencing, GAMT Gene Mutation Analysis, Cerebral Creatine Deficiency Syndrome Type 1 NGS Test

GAMT Gene Guanidinoacetate methyltransferase deficiency NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS), Targeted Gene Panel Sequencing, Sanger Confirmation (if required) on Blood or Extracted DNA or One Drop Blood on FTA Card samples. Results in 3 to 4 Weeks from sample receipt at the laboratory. Free home collection in 300+ cities across India.

NGS Genetic TestUnisexAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the GAMT Gene Guanidinoacetate Methyltransferase Deficiency NGS Genetic Test is to identify pathogenic or likely pathogenic variants in the GAMT gene that cause GAMT deficiency, a treatable inborn error of creatine metabolism. This test enables definitive molecular confirmation of clinically suspected cases, allows carrier testing for at-risk family members, facilitates informed genetic counselling regarding recurrence risks, and supports prenatal or preimplantation genetic diagnosis in families with a known pathogenic variant. Early molecular diagnosis allows timely therapeutic intervention with creatine supplementation and dietary arginine restriction, which can substantially improve neurodevelopmental outcomes.

Test Code
2069
CPT Code
81479
ICD Code
E72.8
Price
₹20,000
Sample Type
Blood or Extracted DNA or One Drop Blood on FTA Card
Result Time
3 to 4 Weeks from sample receipt at the laboratory
Fasting Required
No
Method
Next-Generation Sequencing (NGS), Targeted Gene Panel Sequencing, Sanger Confirmation (if required)
Step 1

Sample Collection

A genetic counselling session is recommended before sample collection to draw a pedigree chart of family members affected with Guanidinoacetate Methyltransferase Deficiency. Clinical history of the patient, including onset of symptoms, developmental milestones, seizure history, family history, and consanguinity details, should be documented. No fasting is required prior to blood collection.

Method: Venipuncture or Heel Prick (for neonates)

Step 2

Laboratory Analysis

A 3-5 mL venous blood sample is collected in an EDTA (lavender top) vacutainer using standard venipuncture technique. For neonates or infants, a heel-prick sample collected on an FTA card is acceptable. Proper sample labeling and chain-of-custody documentation are maintained throughout.

Step 3

Report Delivery

The collected blood sample or extracted DNA is transported to the laboratory under appropriate temperature conditions. DNA extraction is performed and quality-checked before NGS library preparation and sequencing. The report is typically delivered within 3 to 4 weeks through the online portal, email, or WhatsApp.

Timeline: 3 to 4 Weeks from sample receipt at the laboratory

Patient Instructions

1
Before the Test:A pre-test genetic counselling session is recommended. The patient's clinical history, developmental milestones, seizure history, family pedigree, and consanguinity details should be reviewed and documented. No specific preparation such as fasting is required for blood collection.
2
During the Test:A 3-5 mL blood sample is collected in an EDTA vacutainer or a one-drop blood sample is applied to an FTA card. DNA is extracted, quality-assessed, and subjected to next-generation sequencing of the GAMT gene. Data analysis includes alignment, variant calling, and clinical interpretation per ACMG/AMP guidelines.
3
After the Test:Results are typically available within 3 to 4 weeks. The clinical report is shared via the online portal, email, or WhatsApp. Raw data files (FASTQ and VCF) are also provided for transparency. Post-test genetic counselling is recommended to discuss the results, implications, and next steps.

About This Test

Who Should Get This Test

The purpose of the GAMT Gene Guanidinoacetate Methyltransferase Deficiency NGS Genetic Test is to identify pathogenic or likely pathogenic variants in the GAMT gene that cause GAMT deficiency, a treatable inborn error of creatine metabolism. This test enables definitive molecular confirmation of clinically suspected cases, allows carrier testing for at-risk family members, facilitates informed genetic counselling regarding recurrence risks, and supports prenatal or preimplantation genetic diagnosis in families with a known pathogenic variant. Early molecular diagnosis allows timely therapeutic intervention with creatine supplementation and dietary arginine restriction, which can substantially improve neurodevelopmental outcomes.

How to Prepare

  • Collect blood in an EDTA (lavender top) vacutainer
  • Ensure proper patient identification and sample labeling
  • Mix blood gently by inversion 8-10 times immediately after collection
  • For FTA card samples, apply one full drop of blood and allow to air dry completely
  • Store whole blood at 2-8°C if not dispatched immediately
  • Transport the sample to the laboratory within 48-72 hours of collection
  • Include completed test requisition form with clinical history and consent

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"GAMT deficiency is a treatable inborn error of metabolism. Early genetic diagnosis allows timely initiation of creatine and ornithine supplementation combined with arginine restriction, which can significantly improve neurodevelopmental outcomes. Families with a known history of creatine deficiency syndromes or consanguinity should consider carrier testing and prenatal or preimplantation genetic diagnosis."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One Drop Blood on FTA Card
Sample Volume3-5 mL of whole blood or 2-5 µg extracted DNA
ContainerEDTA (Lavender Top) Vacutainer or FTA Card
Collection MethodVenipuncture or Heel Prick (for neonates)

Sample Stability

Sample Rejection Criteria:
  • Sample received in a non-EDTA anticoagulant or wrong collection tube
  • Clotted or hemolyzed blood sample
  • Sample without proper labeling or requisition form
  • DNA extracted with A260/A280 ratio below 1.6 indicating poor purity
  • Insufficient sample volume for DNA extraction
  • Sample received beyond the acceptable stability window

Understanding Your Results

The results of the GAMT Gene Guanidinoacetate Methyltransferase Deficiency NGS Genetic Test indicate whether pathogenic or likely pathogenic variants were identified in the GAMT gene. Interpretation should always be performed in the context of the patient's clinical presentation, biochemical findings, and family history. Genetic counselling is strongly recommended to help families understand the implications of the results.
📊

No Pathogenic Variants Detected

Low probability of GAMT deficiency

📊

Pathogenic or Likely Pathogenic Variant(s) Detected

Confirms diagnosis of GAMT deficiency (biallelic variants) or carrier status (monoallelic variant)

📊

Variant of Uncertain Significance (VUS) Detected

Inconclusive; requires further investigation and genetic counselling

⚠️ When to Consult a Doctor:

Consult a paediatric neurologist, metabolic disease specialist, or clinical geneticist if the test result indicates the presence of pathogenic variants in the GAMT gene. Immediate medical consultation is recommended if your child presents with unexplained developmental delay, intellectual disability, seizures, movement disorders, or behavioral abnormalities. Families with a confirmed pathogenic variant should seek genetic counselling for recurrence risk assessment and family planning options.

Limitations

  • This test does not detect variants in deep intronic regions, regulatory elements, or promoter regions unless specifically targeted
  • Large structural rearrangements or balanced translocations may not be detected by standard NGS analysis
  • The test may identify Variants of Uncertain Significance (VUS) that cannot be definitively classified as pathogenic or benign at the time of reporting
  • Mosaicism at low levels (below ~10% allele frequency) may not be reliably detected
  • This test does not assess for epigenetic changes or mitochondrial DNA variants
  • Biochemical confirmation through guanidinoacetate and creatine level measurement is recommended alongside genetic testing

Risks & Considerations

  • Minor bruising or discomfort at the blood draw site
  • Very small risk of infection at the venipuncture site
  • Psychological impact of genetic diagnosis on the patient and family
  • Possibility of identifying Variants of Uncertain Significance requiring further investigation

Interfering Factors

  • Degraded or low-quality DNA may affect sequencing coverage and accuracy
  • Recent blood transfusion within the past 30 days may result in mixed DNA population
  • Heavily contaminated samples may produce inconclusive results
  • Presence of pseudogenes or highly homologous regions may affect variant calling in certain regions

Compare With Similar Tests

TestGAMT Gene Guanidinoacetate methyltransferase deficiency NGS Genetic TestPlasma/Urine Guanidinoacetate (GAA) LevelsBrain MR Spectroscopy (MRS)Sanger Sequencing of GAMT GeneWhole Exome Sequencing (WES)
ComparisonGAMT Gene Guanidinoacetate methyltransferase deficiency NGS Genetic Test

Frequently Asked Questions

What is GAMT Gene Guanidinoacetate Methyltransferase Deficiency?
GAMT deficiency is a rare autosomal recessive inherited metabolic disorder caused by mutations in the GAMT gene. It results in a deficiency of the enzyme guanidinoacetate methyltransferase, which is essential for the final step of creatine biosynthesis. This leads to accumulation of guanidinoacetate (a neurotoxic compound) and a severe shortage of creatine in the brain and muscles, causing intellectual disability, seizures, and movement disorders.
How is GAMT deficiency inherited?
GAMT deficiency follows an autosomal recessive inheritance pattern. This means the affected individual inherits one mutated copy of the GAMT gene from each parent. Both parents are typically carriers who have one normal and one mutated copy and do not show symptoms. When both parents are carriers, each pregnancy carries a 25% chance of the child being affected, a 50% chance of the child being a carrier, and a 25% chance of the child being unaffected and not a carrier.
Who should get tested for GAMT deficiency?
Testing is recommended for individuals presenting with unexplained developmental delay, intellectual disability, seizures, movement disorders, or behavioral abnormalities, especially when brain MR spectroscopy shows reduced creatine peaks or when biochemical tests reveal elevated guanidinoacetate levels. Carrier testing is also recommended for parents and siblings of an affected individual and for couples with a family history of creatine deficiency syndromes or consanguinity.
What sample is required for the GAMT Gene NGS Genetic Test?
The test can be performed on a 3-5 mL blood sample collected in an EDTA (lavender top) vacutainer. Alternatively, extracted DNA or a one-drop blood sample on an FTA card is also accepted. No fasting is required prior to sample collection.
How long does it take to get the test results?
The turnaround time for the GAMT Gene NGS Genetic Test is approximately 3 to 4 weeks from the date of sample receipt at the laboratory. Results are delivered via the online portal, email, or WhatsApp.
What does a positive (pathogenic variant detected) result mean?
If the test detects two pathogenic or likely pathogenic variants in the GAMT gene (one on each allele), this confirms a diagnosis of GAMT deficiency. This result, combined with clinical and biochemical findings, allows the treating physician to initiate appropriate treatment including creatine supplementation, arginine restriction, and ornithine supplementation. If only one pathogenic variant is detected, the individual is a carrier and typically does not show symptoms.
Is GAMT deficiency treatable?
Yes, GAMT deficiency is considered one of the treatable inborn errors of metabolism. Treatment involves oral creatine monohydrate supplementation to replenish brain creatine levels, dietary protein restriction to reduce arginine intake, and ornithine supplementation to reduce guanidinoacetate accumulation. When treatment is initiated early, especially before significant neurological damage occurs, substantial improvement in seizure control, cognitive function, and motor abilities has been reported.
What is the cost of the GAMT Gene NGS Genetic Test at DNA Labs India?
The GAMT Gene Guanidinoacetate Methyltransferase Deficiency NGS Genetic Test is available at DNA Labs India for INR 20,000. This cost includes NGS genetic testing, home sample collection (free for online bookings), a detailed clinical report, and raw data files (FASTQ and VCF).
Is genetic counselling available with this test?
Yes, DNA Labs India offers a genetic counselling session as part of the testing process. A pre-test counselling session is recommended to document the family pedigree and clinical history, while a post-test session helps families understand the results, inheritance implications, recurrence risks, and available treatment or family planning options.
Can this test be done from home?
Yes, DNA Labs India offers free home sample collection for online bookings across major cities in India, including Mumbai, Delhi, Bangalore, Hyderabad, Chennai, Kolkata, Pune, Ahmedabad, and many more. A trained phlebotomist will visit your home for blood sample collection at a time convenient to you.
What is NGS technology and why is it used for this test?
Next-Generation Sequencing (NGS) is an advanced molecular biology technology that allows parallel sequencing of millions of DNA fragments simultaneously. For the GAMT Gene NGS Genetic Test, NGS enables comprehensive analysis of all coding exons and flanking intronic regions of the GAMT gene in a single test run. This approach is more efficient and thorough than traditional Sanger sequencing, as it can detect a wide range of variant types including point mutations, small insertions, deletions, and splice-site variants.
Does DNA Labs India provide raw sequencing data along with the clinical report?
Yes, DNA Labs India is the only laboratory that provides raw data files, including FASTQ files (raw sequencing reads) and VCF files (variant call format), alongside the conclusive clinical test report. This transparency allows the treating physician or an independent geneticist to review the raw data, verify variant calls, and perform additional analyses if needed.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.